Evidence map›Paper›PMID 29296081›Full record

ArticleInternational journal of nanomedicine2017

Effect of dacarbazine on CD44 in live melanoma cells as measured by atomic force microscopy-based nanoscopy.

Xun Huang, Jiexiang He, Huan-Tian Zhang, Kai Sun, Jie Yang, Huajun Wang, Hongxin Zhang, Zhenzhao Guo, Zhen-Gang Zha, Changren Zhou

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Melanoma in the Eyes of Mechanobiology.Frontiers in cell and developmental biology · 2020
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xun HuangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Jinan University.
Jiexiang HeDepartment of Materials Science and Engineering, Jinan University.
Huan-Tian ZhangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Jinan University.
Kai SunDepartment of Materials Science and Engineering, Jinan University.
Jie YangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Jinan University.
Huajun WangDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Jinan University.
Hongxin ZhangDepartment of Materials Science and Engineering, Jinan University.
Zhenzhao GuoDepartment of Materials Science and Engineering, Jinan University.
Zhen-Gang ZhaDepartment of Bone and Joint Surgery, The First Affiliated Hospital of Jinan University.
Changren ZhouDepartment of Materials Science and Engineering, Jinan University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD44 ligand-receptor interactions are known to be involved in regulating cell migration and tumor cell metastasis. High expression levels of CD44 correlate with a poor prognosis of melanoma patients. In order to understand not only the mechanistic basis for dacarbazine (DTIC)-based melanoma treatment but also the reason for the poor prognosis of melanoma patients treated with DTIC, dynamic force spectroscopy was used to structurally map single native CD44-coupled receptors on the surface of melanoma cells. The effect of DTIC treatment was quantified by the dynamic binding strength and the ligand-binding free-energy landscape. The results demonstrated no obvious effect of DTIC on the unbinding force between CD44 ligand and its receptor, even when the CD44 nanodomains were reduced significantly. However, DTIC did perturb the kinetic and thermodynamic interactions of the CD44 ligand-receptor, with a resultant greater dissociation rate, lower affinity, lower binding free energy, and a narrower energy valley for the free-energy landscape. For cells treated with 25 and 75 μg/mL DTIC for 24 hours, the dissociation constant for CD44 increased 9- and 70-fold, respectively. The CD44 ligand binding free energy decreased from 9.94 for untreated cells to 8.65 and 7.39 kcal/mol for DTIC-treated cells, which indicated that the CD44 ligand-receptor complexes on DTIC-treated melanoma cells were less stable than on untreated cells. However, affinity remained in the micromolar range, rather than the millimolar range associated with nonaffinity ligands. Hence, the CD44 receptor could still be activated, resulting in intracellular signaling that could trigger a cellular response. These results demonstrate DTIC perturbs, but not completely inhibits, the binding of CD44 ligand to membrane receptors, suggesting a basis for the poor prognosis associated with DTIC treatment of melanoma. Overall, atomic force microscopy-based nanoscopic methods offer thermodynamic and kinetic insight into the effect of DTIC on the CD44 ligand-binding process.

Indexed as

ActinsAnimalsCell Line, TumorCell SurvivalDacarbazineHyaluronan ReceptorsKineticsMelanomaMiceMicroscopy, Atomic ForceQuantum DotsSingle Molecule ImagingTubulinActinsCd44 protein, mouseDacarbazineHyaluronan ReceptorsTubulinaffinityatomic force microscopydynamic force spectroscopykinetic and thermodynamic interactionsnanoindentationtumor

Identifiers

PMID29296081
PMCPMC5739545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.